Advertisement
UK markets close in 12 minutes
  • FTSE 100

    8,071.47
    +31.09 (+0.39%)
     
  • FTSE 250

    19,592.93
    -126.44 (-0.64%)
     
  • AIM

    752.77
    -1.92 (-0.25%)
     
  • GBP/EUR

    1.1653
    +0.0008 (+0.07%)
     
  • GBP/USD

    1.2483
    +0.0021 (+0.17%)
     
  • Bitcoin GBP

    50,838.53
    -1,154.26 (-2.22%)
     
  • CMC Crypto 200

    1,372.81
    -9.77 (-0.71%)
     
  • S&P 500

    5,003.47
    -68.16 (-1.34%)
     
  • DOW

    37,822.07
    -638.85 (-1.66%)
     
  • CRUDE OIL

    82.35
    -0.46 (-0.56%)
     
  • GOLD FUTURES

    2,346.10
    +7.70 (+0.33%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,900.23
    -188.47 (-1.04%)
     
  • CAC 40

    8,017.70
    -74.16 (-0.92%)
     

Why This Biotech Stock Is Defying A Hematology-Related Pitfall

Why This Biotech Stock Is Defying A Hematology-Related Pitfall

GlycoMimetics defied a hematology biotech pitfall Tuesday, breaking out on strong cancer drug data.